Visual and Patient-Reported Outcomes of a Non-Diffractive Extended Depth-of-Focus Intraocular Lens with Micro-Monovision in Eyes with Early Macular Pathology
Clinical Ophthalmology · 2026-07 · Volume 20 · 1-14
DOI: 10.2147/opth.s618031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ophthalmology, 2026-07. Verfasst von Elif Demircan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Prism Eye Institute, Oakville, ON, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To evaluate visual and patient-reported outcomes after bilateral implantation of a non-diffractive extended depth of focus (EDOF) IOL (AcrySof IQ Vivity, Alcon) in patients with early macular pathology.
Design
Single-site, prospective, non-comparative pilot cohort study. Patients and Methods: The study included 20 patients (40 eyes) undergoing bilateral cataract surgery with at least one eye with early-stage macular pathology, specifically age-related macular degeneration (AREDS category 2) or epiretinal membrane (stage 0). All patients received bilateral implantation of the non-diffractive EDOF IOL targeted for micro-monovision. Primary outcomes were monocular corrected distance visual acuity (CDVA) and distance-corrected intermediate visual acuity (DCIVA) at 3 months. Secondary outcomes included binocular CDVA, DCIVA, and distance-corrected near visual acuity (DCNVA); uncorrected distance, intermediate and near visual acuity (UDVA, UIVA, UNVA); refractive outcomes; contrast sensitivity and patient-reported outcomes, including satisfaction and visual disturbances.
Results
At 3 months, median (IQR) monocular CDVA, DCIVA, and DCNVA were 0.00 (0.00-0.10), 0.18 (0.08-0.28), and 0.40 (0.30-0.50) logMAR, respectively. Binocular CDVA, DCIVA, and DCNVA were 0.00 (0.00-0.00), 0.13 (0.08-0.18), and 0.35 (0.22-0.40). Binocular UDVA, UIVA, and UNVA were 0.00 (0.00-0.00), 0.08 (-0.01-0.11), and 0.30 (0.20-0.33) logMAR, respectively. 90% of dominant and 95% of non-dominant eyes were within ±0.50 D of the intended outcome. Photopic contrast sensitivity was within normal range, while mesopic values were near the lower end of normal. Most patients (90%) were satisfied with their vision. Visual disturbances were low in frequency, severity, and bothersomeness, with median Rasch-calibrated scores of 32, 27, and 29, respectively.
Conclusion
In patients with early macular pathology, bilateral implantation of a non-diffractive EDOF IOL demonstrated promising distance and intermediate vision, favorable near visual outcomes, and high patient satisfaction with minimal visual disturbances. Larger, prospective, comparative studies are warranted to define candidacy for patients with macular pathology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Prism Eye Institute, Oakville, ON, Canada.
- John A. Moran Eye Center, University of Utah, Salt Lake, UT, USA.
- Institute for Better Health, Trillium Health Partners, Mississauga, ON, Canada.
- Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Elif Demircan, Iqbal Ike K Ahmed
Zitieren
APA
Demircan, E., Rabinovitch, D., Ahmed, I. I. K., & Varma, D. K. (2026). Visual and Patient-Reported Outcomes of a Non-Diffractive Extended Depth-of-Focus Intraocular Lens with Micro-Monovision in Eyes with Early Macular Pathology. Clinical Ophthalmology, Volume 20, 1-14. https://doi.org/10.2147/opth.s618031
Vancouver
Demircan E, Rabinovitch D, Ahmed IIK, Varma DK. Visual and Patient-Reported Outcomes of a Non-Diffractive Extended Depth-of-Focus Intraocular Lens with Micro-Monovision in Eyes with Early Macular Pathology. Clinical Ophthalmology. 2026;Volume 20:1-14. doi:10.2147/opth.s618031
BibTeX
@article{Demircan2026,
author = {Demircan, Elif and Rabinovitch, David and Ahmed, Iqbal Ike K and Varma, Devesh K},
title = {Visual and Patient-Reported Outcomes of a Non-Diffractive Extended Depth-of-Focus Intraocular Lens with Micro-Monovision in Eyes with Early Macular Pathology},
journal = {Clinical Ophthalmology},
year = {2026},
volume = {Volume 20},
pages = {1--14},
doi = {10.2147/opth.s618031}
}
EUVIMED